CytomX Therapeutics, Inc.
CTMX
$3.79
-$0.09-2.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 36.20% | 22.14% | 15.24% | -46.84% | -42.34% |
| Total Receivables | -35.13% | -51.40% | -32.65% | -85.16% | -9.59% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 35.68% | 22.28% | 49.38% | 26.41% | -28.35% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 34.12% | 20.16% | 15.06% | -48.20% | -41.34% |
|
|
|||||
| Total Current Assets | 34.12% | 20.16% | 15.06% | -48.20% | -41.34% |
| Net Property, Plant & Equipment | -55.67% | -46.15% | -41.71% | -37.27% | -34.46% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -24.87% | -23.55% | -22.26% | -21.07% | -20.03% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 42.54% | -1.64% | 9.16% | 9.23% | 9.30% |
| Total Assets | 25.75% | 13.87% | 9.95% | -46.67% | -40.27% |
|
|
|||||
| Total Accounts Payable | 19.58% | -54.57% | -62.85% | -85.95% | -25.38% |
| Total Accrued Expenses | 14.88% | -26.40% | -16.73% | -25.80% | -29.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -17.59% | 11.90% | 11.97% | 12.04% | 12.12% |
| Total Finance Division Other Current Liabilities | -59.97% | -76.61% | -82.05% | -72.43% | -49.19% |
| Total Other Current Liabilities | -59.97% | -76.61% | -82.05% | -72.43% | -49.19% |
| Total Current Liabilities | -45.65% | -65.59% | -72.54% | -65.27% | -44.99% |
|
|
|||||
| Total Current Liabilities | -45.65% | -65.59% | -72.54% | -65.27% | -44.99% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -79.06% | -64.95% | -54.82% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -80.81% | -73.85% | -64.42% | -67.98% | -63.10% |
| Total Liabilities | -56.56% | -68.69% | -71.04% | -66.05% | -51.46% |
|
|
|||||
| Common Stock & APIC | 17.33% | 14.96% | 15.05% | 2.23% | 2.25% |
| Retained Earnings | -2.95% | 3.94% | 6.70% | 5.86% | 4.41% |
| Treasury Stock & Other | 311.11% | 160.00% | 925.00% | 90.00% | -71.58% |
| Total Common Equity | 21,812.28% | 557.91% | 483.99% | 179.07% | 99.04% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 21,812.28% | 557.91% | 483.99% | 179.07% | 99.04% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 21,812.28% | 557.91% | 483.99% | 179.07% | 99.04% |
|
|
|||||